In vitro infection of lymphoid cells by thymotropic radiation leukemia virus grown in vitro.
Murine lymphoid cells were infected in vitro with purified leukemogenic radiation leukemia virus (RadLV) produced by virus-induced lymphoblast cell lines. Thymocytes were shown to be highly susceptible to infection by the virus, whereas murine or other fibroblasts were refractory to it. Murine bone marrow and spleen cells were shown to be much less sensitive to infection by this thymotropic RadLV. By comparison, a B-tropic RadLV isolate (RadLV), propagated on a mouse fibroblast cell line, was noninfectious for lymphoid cells but infected fibroblasts. A correlation was shown to exist between in vitro infection of thymocytes, as assayed by immunofluorescence, and in vivo leukemogenicity of the thymotropic RadLV. This constitutes a rapid in vitro test for in vivo leukemogenicity of a natural lymphatic leukemia virus.
D000818:Animals; D001402:B-Lymphocytes / Q000382:microbiology; D002460:Cell Line; D005347:Fibroblasts / Q000382:microbiology; D009052:Leukemia Virus, Murine / Q000472:pathogenicity*; D007942:Leukemia, Experimental / Q000382:microbiology*; D008221:Lymphoid Tissue / Q000382:microbiology*; D051379:Mice; D011817:Rabbits; D051381:Rats; D012190:Retroviridae / Q000472:pathogenicity; D013045:Species Specificity; D013601:T-Lymphocytes / Q000382:microbiology; D013997:Time Factors